Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of C...
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19
About this item
Full title
Author / Creator
Publisher
London: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Here, we advocate a highly favourable opportunity for the treatment of COVID-19 disease by repurposing a long-serving medical agent with an excellent history of clinical use, namely heparin. Heparin is best known as an anticoagulant, but it also exhibits direct antiviral activity against many enveloped viruses and has anti-inflammatory activity. Th...
Alternative Titles
Full title
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7687307
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7687307
Other Identifiers
ISSN
1470-2118
E-ISSN
1473-4893
DOI
10.7861/clinmed.2020-0351
